BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 15590582)

  • 1. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of and risk factors for cataract among diabetes clinic attenders.
    Janghorbani MB; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Mar; 7(1):13-25. PubMed ID: 10652168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.
    Janghorbani M; Amini M; Ghanbari H; Safaiee H
    Ophthalmic Epidemiol; 2003 Apr; 10(2):81-95. PubMed ID: 12660857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.
    Janghorbani M; Rezvanian H; Kachooei A; Ghorbani A; Chitsaz A; Izadi F; Amini M
    Acta Neurol Scand; 2006 Dec; 114(6):384-91. PubMed ID: 17083338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of switching to insulin from non-insulin therapy in patients with type 2 diabetes mellitus.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2011 Apr; 92(1):111-7. PubMed ID: 21051096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2005 Oct; 70(1):71-80. PubMed ID: 16126125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors.
    Janghorbani M; Amini M
    Metab Syndr Relat Disord; 2007 Sep; 5(3):243-54. PubMed ID: 18370778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
    Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
    Schiel R; Müller UA; Braun A; Stein G; Kath R
    Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients.
    Rotimi C; Daniel H; Zhou J; Obisesan A; Chen G; Chen Y; Amoah A; Opoku V; Acheampong J; Agyenim-Boateng K; Eghan BA; Oli J; Okafor G; Ofoegbu E; Osotimehin B; Abbiyesuku F; Johnson T; Fasanmade O; Doumatey A; Aje T; Collins F; Dunston G
    Ethn Dis; 2003; 13(2 Suppl 2):S110-7. PubMed ID: 13677425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.
    Hadaegh F; Zabetian A; Harati H; Azizi F
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):310-5. PubMed ID: 16868890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women.
    Rossi R; Turco V; Origliani G; Modena MG
    J Hypertens; 2006 Oct; 24(10):2017-22. PubMed ID: 16957562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-generation comparison of type-2 diabetes in 73 Indian families.
    Panikar VK; Joshi SR; Kakraniya P; Nasikkar N; Santavana C
    J Assoc Physicians India; 2008 Aug; 56():601-4. PubMed ID: 19051704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.
    Fox CS; Pencina MJ; Meigs JB; Vasan RS; Levitzky YS; D'Agostino RB
    Circulation; 2006 Jun; 113(25):2914-8. PubMed ID: 16785337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius.
    Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
    J Hypertens; 2008 Sep; 26(9):1742-9. PubMed ID: 18698207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative role of major risk factors for Type 2 diabetes development in the historical cohort of the Brisighella Heart Study: an 8-year follow-up.
    Cicero AF; Dormi A; Nascetti S; Panourgia MP; Grandi E; D'Addato S; Gaddi A
    Diabet Med; 2005 Sep; 22(9):1263-6. PubMed ID: 16108859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.
    Meisinger C; Kandler U; Ladwig KH
    Psychosom Med; 2009 Sep; 71(7):784-8. PubMed ID: 19592514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.